Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology. / Kofoed, Kristian; Schneider, Uffe Vest; Scheel, Troels; Andersen, Ove; Eugen-Olsen, Jesper.

I: Clinical Chemistry, Bind 52, Nr. 7, 2006, s. 1284-93.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Kofoed, K, Schneider, UV, Scheel, T, Andersen, O & Eugen-Olsen, J 2006, 'Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology', Clinical Chemistry, bind 52, nr. 7, s. 1284-93. https://doi.org/10.1373/clinchem.2006.067595

APA

Kofoed, K., Schneider, U. V., Scheel, T., Andersen, O., & Eugen-Olsen, J. (2006). Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology. Clinical Chemistry, 52(7), 1284-93. https://doi.org/10.1373/clinchem.2006.067595

Vancouver

Kofoed K, Schneider UV, Scheel T, Andersen O, Eugen-Olsen J. Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology. Clinical Chemistry. 2006;52(7):1284-93. https://doi.org/10.1373/clinchem.2006.067595

Author

Kofoed, Kristian ; Schneider, Uffe Vest ; Scheel, Troels ; Andersen, Ove ; Eugen-Olsen, Jesper. / Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology. I: Clinical Chemistry. 2006 ; Bind 52, Nr. 7. s. 1284-93.

Bibtex

@article{3d4ad2bb03084576894d5811177397cd,
title = "Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology",
abstract = "Sepsis is a common and often fatal disease. Because sepsis can be caused by many different organisms, biomarkers that can aid in diagnosing sepsis and monitoring treatment efficacy are highly warranted. New sepsis markers may provide additional information to complement the currently used markers.",
author = "Kristian Kofoed and Schneider, {Uffe Vest} and Troels Scheel and Ove Andersen and Jesper Eugen-Olsen",
year = "2006",
doi = "http://dx.doi.org/10.1373/clinchem.2006.067595",
language = "English",
volume = "52",
pages = "1284--93",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry, Inc.",
number = "7",

}

RIS

TY - JOUR

T1 - Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology

AU - Kofoed, Kristian

AU - Schneider, Uffe Vest

AU - Scheel, Troels

AU - Andersen, Ove

AU - Eugen-Olsen, Jesper

PY - 2006

Y1 - 2006

N2 - Sepsis is a common and often fatal disease. Because sepsis can be caused by many different organisms, biomarkers that can aid in diagnosing sepsis and monitoring treatment efficacy are highly warranted. New sepsis markers may provide additional information to complement the currently used markers.

AB - Sepsis is a common and often fatal disease. Because sepsis can be caused by many different organisms, biomarkers that can aid in diagnosing sepsis and monitoring treatment efficacy are highly warranted. New sepsis markers may provide additional information to complement the currently used markers.

U2 - http://dx.doi.org/10.1373/clinchem.2006.067595

DO - http://dx.doi.org/10.1373/clinchem.2006.067595

M3 - Journal article

VL - 52

SP - 1284

EP - 1293

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 7

ER -

ID: 40140083